Tapewire

Nasdaq · USD

ELTX

Elicio Therapeutics, Inc.

Export transactions ↓
Tapewire entity
299
SEC CIK
0001601485
Parsed reports
140

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 09, 2021 Filed Feb 12, 2021 00:23 UTC ConversionCommon Stock 14,783 $11.57 $171,039.31
Disclosure

SEC source: 0001567619-21-003191 · doc1.xml · nonDerivative · entry 3

OMENN GILBERT S · CIK 0001184227 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Trust

Disclosed balance after: 80,326

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Gilbert S. Omenn Revocable Trust.

Read SEC document
February 09, 2021 Filed Feb 12, 2021 00:23 UTC ConversionCommon Stock 23,391 $11.57 $270,633.87
Disclosure

SEC source: 0001567619-21-003191 · doc1.xml · nonDerivative · entry 2

OMENN GILBERT S · CIK 0001184227 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Trust

Disclosed balance after: 65,543

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Gilbert S. Omenn Revocable Trust.

Read SEC document
February 09, 2021 Filed Feb 12, 2021 00:23 UTC ConversionCommon Stock 23,483 $11.57 $271,698.31
Disclosure

SEC source: 0001567619-21-003191 · doc1.xml · nonDerivative · entry 1

OMENN GILBERT S · CIK 0001184227 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Trust

Disclosed balance after: 42,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Gilbert S. Omenn Revocable Trust.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 19:22 UTC OtherWarrant to Purchase Common Stock · Derivative 367,590 $0.00 Strike: $6.43 $0.00
Disclosure

SEC source: 0001567619-21-003189 · doc1.xml · derivative · entry 8

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 367,590 shares

Expires 2028-07-05

F2 · derivative.exercise_date: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's IPO price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's IPO, the Issuer withheld 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 19:22 UTC ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $16.00 $579,901.31
Disclosure

SEC source: 0001567619-21-003189 · doc1.xml · derivative · entry 7

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · Not disclosed shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The convertible promissory note converted immediately prior to the consummation of the IPO into Common Stock.

F5 · derivative.expiration_date: The convertible promissory note ("Convertible Note") had a maturity date of August 21, 2021 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $18.00 per Common Share.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 19:22 UTC ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $16.00 $216,832.88
Disclosure

SEC source: 0001567619-21-003189 · doc1.xml · derivative · entry 6

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 216,832.88 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The convertible promissory note converted immediately prior to the consummation of the IPO into Common Stock.

F4 · derivative.expiration_date: The convertible promissory note ("Convertible Note") had a maturity date of May 28, 2021 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $18.00 per Common Share.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 19:22 UTC SaleCommon Stock 246,720 $16.00 $3,947,520.00
Disclosure

SEC source: 0001567619-21-003189 · doc1.xml · nonDerivative · entry 5

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 576,397

F2 · balance_after: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's IPO price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's IPO, the Issuer withheld 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 19:22 UTC OtherCommon Stock 367,590 $6.43 $2,363,603.70
Disclosure

SEC source: 0001567619-21-003189 · doc1.xml · nonDerivative · entry 4

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 823,117

F2 · balance_after: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's IPO price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's IPO, the Issuer withheld 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 19:22 UTC ConversionCommon Stock 50,122 $11.57 $579,911.54
Disclosure

SEC source: 0001567619-21-003189 · doc1.xml · nonDerivative · entry 3

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 455,527

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2021 Filed Feb 11, 2021 19:22 UTC ConversionCommon Stock 18,741 $11.57 $216,833.37
Disclosure

SEC source: 0001567619-21-003189 · doc1.xml · nonDerivative · entry 2

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 405,405

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2021 Filed May 27, 2022 20:20 UTC Amendment
Venkatesan JayDirector · See Remarks
OtherWarrant to Purchase Common Stock · Derivative 396,329 $0.00 Strike: $6.43 $0.00
Disclosure

SEC source: 0001601485-22-000045 · wf-form4a_165368278065712.xml · derivative · entry 4

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 396,329 shares

Expires 2028-07-05

F1 · derivative.exercise_date: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 396,329 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 159,177 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 237,152 shares of common stock.

Read SEC document
February 09, 2021 Filed May 27, 2022 20:20 UTC Amendment
Venkatesan JayDirector · See Remarks
ConversionCommon Stock 262 $11.57 $3,031.34
Disclosure

SEC source: 0001601485-22-000045 · wf-form4a_165368278065712.xml · nonDerivative · entry 3

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,439,525

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2021 Filed May 27, 2022 20:20 UTC Amendment
Venkatesan JayDirector · See Remarks
SaleCommon Stock 159,177 $16.00 $2,546,832.00
Disclosure

SEC source: 0001601485-22-000045 · wf-form4a_165368278065712.xml · nonDerivative · entry 2

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,367,263

F1 · kind: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 396,329 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 159,177 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 237,152 shares of common stock.

Read SEC document
February 09, 2021 Filed May 27, 2022 20:20 UTC Amendment
Venkatesan JayDirector · See Remarks
OtherCommon Stock 396,329 $6.43 $2,548,395.47
Disclosure

SEC source: 0001601485-22-000045 · wf-form4a_165368278065712.xml · nonDerivative · entry 1

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,598,440

Read SEC document
February 09, 2021 Filed May 27, 2022 16:19 UTC Amendment OtherWarrant to Purchase Common Stock · Derivative 614,310 $0.00 Strike: $6.43 $0.00
Disclosure

SEC source: 0001601485-22-000044 · wf-form4a_165368270982659.xml · derivative · entry 3

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 614,310 shares

Expires 2028-07-05

F1 · derivative.exercise_date: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.

Read SEC document
February 09, 2021 Filed May 27, 2022 16:19 UTC Amendment SaleCommon Stock 246,720 $16.00 $3,947,520.00
Disclosure

SEC source: 0001601485-22-000044 · wf-form4a_165368270982659.xml · nonDerivative · entry 2

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 823,117

F1 · kind: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.

Read SEC document
February 09, 2021 Filed May 27, 2022 16:19 UTC Amendment OtherCommon Stock 614,310 $6.43 $3,950,013.30
Disclosure

SEC source: 0001601485-22-000044 · wf-form4a_165368270982659.xml · nonDerivative · entry 1

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,069,837

Read SEC document
February 04, 2021 Filed Feb 8, 2021 12:59 UTC
Neylan John F.See Remarks
GrantStock Option (Right to Buy) · Derivative 70,012 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001567619-21-002413 · doc1.xml · derivative · entry 1

Neylan John F. · CIK 0001640447 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,012

Underlying: Common Stock · 70,012 shares

Expires 2031-02-03

F1 · derivative.exercise_date: 1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 4, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 04, 2021 Filed Feb 8, 2021 12:58 UTC
Goldberg ItzhakSee Remarks
GrantStock Option (Right to Buy) · Derivative 70,012 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001567619-21-002412 · doc1.xml · derivative · entry 1

Goldberg Itzhak · CIK 0001607858 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,012

Underlying: Common Stock · 70,012 shares

Expires 2031-02-03

F1 · derivative.exercise_date: 1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 4, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 04, 2021 Filed Feb 8, 2021 17:57 UTC
Venkatesan JayDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 178,920 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001567619-21-002411 · doc1.xml · derivative · entry 1

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,920

Underlying: Common Stock · 178,920 shares

Expires 2031-02-03

F1 · derivative.exercise_date: 1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 4, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 04, 2021 Filed Feb 8, 2021 12:56 UTC GrantStock Option (Right to Buy) · Derivative 70,012 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001567619-21-002410 · doc1.xml · derivative · entry 1

Rhodes Jennifer J · CIK 0001568249 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,012

Underlying: Common Stock · 70,012 shares

Expires 2031-02-03

F1 · derivative.exercise_date: 1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 4, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.